Top Markets
Coin of the day
Cellectis S.A. Cellectis S.A.

Cellectis S.A.

ALCLS
Rangering i aksjer #17125
Cellectis S.A., a clinical-stage biotechnology company founded in 1999 and... Cellectis S.A., a clinical-stage biotechnology company founded in 1999 and headquartered in Paris, France, concentrates on immuno-oncology. The firm engineers therapeutic solutions utilizing gene-edited T-cells, which are modified to display chimeric antigen receptors (CARs) for the specific identification and destruction of cancer cells. Its operations are divided into two principal segments: Therapeutics and Plants. The company's pipeline features several allogeneic CAR T-cell product candidates. These include UCART19, aimed at CD19-expressing hematologic malignancies such as acute lymphoblastic leukemia; ALLO-501 and ALLO-501A, developed to treat relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma; ALLO-316, targeting renal cell carcinoma; UCART123, for acute myeloid leukemia; and UCART22, addressing B-cell acute lymphoblastic leukemia. Additionally, Cellectis is advancing UCARTCS1 and ALLO-715 for the treatment of multiple myeloma. Cellectis has forged significant strategic partnerships and alliances with companies including Allogene Therapeutics, Inc., Les Laboratoires Servier, The University of Texas M.D. Anderson Cancer Center, and Iovance Biotherapeutics. It also maintains a strategic research and development collaboration with Cytovia Therapeutics, Inc.
Aksjekurs
$3.56
Markedsverdi
$257.37M
Endring (1 dag)
5.26%
Endring (1 år)
38.35%
Land
FR
Handel Cellectis S.A. (ALCLS)

Kategori

Aksjeprishistorikk for Cellectis S.A. (ALCLS)
Høyeste sluttskurs: $3.46 den 2026-09-01

Laveste sluttskurs: $17.72 den 2007-02-01
Aksjeprishistorikk for Cellectis S.A. fra 2007 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -20.49%
2025 169.48%
2024 -42.86%
2023 40.69%
2022 -74.52%
2021 -70.75%
2020 74.88%
2019 -10.96%
2018 -29.07%
2017 53.46%
2016 -41.97%
2015 106.63%
2014 307.22%
2013 -61.60%
2012 7.76%
2011 -4.53%
2010 -42.92%
2009 103.43%
2008 -44.49%
2007 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$122.21 -10.03%
AU
$757.71 8.20%
CH